{
    "Trade/Device Name(s)": [
        "CRYOcheck Clot APCR",
        "CRYocheck\u2122 Clot APCR\u2122",
        "CryoCheckTM Clot APCRTM"
    ],
    "Submitter Information": "Precision BioLogic Inc.",
    "510(k) Number": "K060284",
    "Predicate Device Reference 510(k) Number(s)": [
        "K992456"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "GGW"
    ],
    "Summary Letter Date": "April 28, 2006",
    "Summary Letter Received Date": "May 2, 2006",
    "Submission Date": "February 2, 2006",
    "Regulation Number(s)": [
        "21CFR864.7925"
    ],
    "Regulation Name(s)": [
        "Partial Thromboplastin Time Tests"
    ],
    "Analyte Class(es)": [
        "coagulation",
        "hematology"
    ],
    "Analyte(s)": [
        "Activated protein C resistance"
    ],
    "Specimen Type(s)": [
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Citrate tube"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Clotting assay",
        "Dilute Russell's viper venom time (dRVT)"
    ],
    "Methodologies": [
        "Two-stage clotting test system"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for CRYOcheck Clot APCR, a clotting assay for resistance to activated protein C in plasma from individuals with factor V Leiden mutation.",
    "Indications for Use Summary": "Screening for resistance to activated protein C in citrated human plasma from individuals with the factor V Leiden mutation.",
    "fda_folder": "Hematology"
}